| Dr Yogen Dave, MD | |
|
107 Newtown Rd, Danbury, CT 06810-4146 | |
| (203) 748-7433 | |
| Not Available |
| Full Name | Dr Yogen Dave |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 20 Years |
| Location | 107 Newtown Rd, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275791279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 048713 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Specialty Care, P.c. | 2567353121 | 21 |
News Archive
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of these transplants could mean more organs being available for the nearly 100,000 people in the U.S. currently waiting for a kidney transplant.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
A new research project at the University of Leicester will review the accuracy of medical diagnoses. Evaluating diagnostic strategy is crucial to clinical practice as it helps maximise the efficacy of the treatments which are offered to patients. Many lives are affected every day by the diagnoses made by hospitals and medical doctors, and it is vital that diagnoses are accurate.
Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).
› Verified 5 days ago
| Entity Name | Advanced Specialty Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053340943 PECOS PAC ID: 2567353121 Enrollment ID: O20040323000757 |
News Archive
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of these transplants could mean more organs being available for the nearly 100,000 people in the U.S. currently waiting for a kidney transplant.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
A new research project at the University of Leicester will review the accuracy of medical diagnoses. Evaluating diagnostic strategy is crucial to clinical practice as it helps maximise the efficacy of the treatments which are offered to patients. Many lives are affected every day by the diagnoses made by hospitals and medical doctors, and it is vital that diagnoses are accurate.
Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yogen Dave, MD 107 Newtown Rd, Danbury, CT 06810-4146 Ph: (203) 748-7433 | Dr Yogen Dave, MD 107 Newtown Rd, Danbury, CT 06810-4146 Ph: (203) 748-7433 |
News Archive
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of these transplants could mean more organs being available for the nearly 100,000 people in the U.S. currently waiting for a kidney transplant.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
A new research project at the University of Leicester will review the accuracy of medical diagnoses. Evaluating diagnostic strategy is crucial to clinical practice as it helps maximise the efficacy of the treatments which are offered to patients. Many lives are affected every day by the diagnoses made by hospitals and medical doctors, and it is vital that diagnoses are accurate.
Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).
› Verified 5 days ago
Jane Veronica Petroff, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 57 North St Ste 216, Danbury, CT 06810 Phone: 203-797-9209 Fax: 203-748-7692 | |
Dr. Neetu Godhwani, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 107 Newtown Rd Ste 1b, Danbury, CT 06810 Phone: 203-748-7433 Fax: 203-790-5324 |